| Study characteristics |
| Methods |
open label, randomized cross‐over, intention to treat |
| Participants |
8 patients with
congestive heart failure, class II‐III
Age: 44‐65
Male: 7, Female: 1 |
| Interventions |
Torsemide
Continuous: loading dose of 25 mg then 75 mg x 24 hours (3.125 mg/hour)
Bolus: 100 mg intravenously |
| Outcomes |
Urine output, sodium excretion at 24 hours |
| Notes |
Selection Bias: B
Performance Bias: B
Exclusion Bias: A
Detection Bias: B
Overall score: B |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
